Reported Q: Q2 2025 Rev YoY: N/A EPS YoY: 0.0% Move: +546.39%
Startech Labs Inc
LAAB
$1.700 546.39%
Exchange PNK Sector Technology Industry Software Application
Q2 2025
Published: Dec 31, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for LAAB

Reported

Report Date

Dec 31, 2024

Quarter Q2 2025

Revenue

N/A

YoY: N/A

EPS

0.00

YoY: 0.0%

Market Move

+546.39%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • EPS of $0.00 increased by 0% from previous year
  • Net income of -11.93K
  • "" -
LAAB
Company LAAB

Executive Summary

Startech Labs Inc (LAAB) reported a QQ2 2025 period with negative profitability and ongoing cash burn, while revenue figures were not disclosed in the provided data set. The company posted an operating loss of -4,559 USD and a net loss of -11,927 USD for the quarter, accompanied by an EPS of -0.0002. Interest expense of 7,368 USD markedly exceeded operating results, contributing to a negative EBITDA of -4,559 USD and a net income stream that remained deeply negative despite a modest implied improvement in quarterly operating metrics. On a year-over-year basis, the reported operating income and net income metrics are shown as improving (operating income YoY +26.86%, net income YoY +12.31%), and EPS QoQ growth is noted at +50%, though the absence of revenue data limits meaningful margin analysis. Cash flow from operations was -1,050 USD for QQ2 2025, with free cash flow also -1,050 USD, signaling continued cash burn and liquidity proximity concerns.

From a balance-sheet perspective, total liabilities stood at 410,626 USD with debt of 129,402 USD. The reported retained earnings are deeply negative at -39,125,896 USD, and stockholders’ equity was -410,626 USD, implying substantial accumulated deficits and reported leverage that warrants close monitoring. Liquidity indicators in the data are effectively nil (current ratio 0, quick ratio 0, cash ratio 0), underscoring financing fragility. The company’s valuation ratios are also challenging: price-to-book around -1.22 and price-to-earnings around -10.49, with an enterprise value multiple of -138.13, all signaling a discount to fundamental benchmarks that may reflect the firm’s distress or a niche market stance.

Given the absence of an earnings call transcript in the dataset, management commentary cannot be incorporated directly into this analysis. The quantitative signals point to a high-risk, highly uncertain near-term trajectory, with potential upside contingent on a material revenue generation plan and meaningful deleveraging or capital-structure relief.

Key Performance Indicators

Operating Income
Increasing
-4.56K
QoQ: 74.01% | YoY: 26.86%
Net Income
Increasing
-11.93K
QoQ: 52.27% | YoY: 12.31%
EPS
Stable
0.00
QoQ: 50.00% | YoY: 0.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 0.00 -0.02 +0.0% View
Q1 2026 0.00 -0.03 +0.0% View
Q3 2025 0.00 0.00 +0.0% View
Q2 2025 0.00 0.00 +0.0% View
Q1 2025 0.00 0.00 +0.0% View